Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Pelvic Neoplasms 1Cholangiocarcinoma 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Abdominal Neoplasms 1

Interventions

Surveys and Questionnaires 2Gemcitabine 2spartalizumab 1liposomal doxorubicin 1Watchful Waiting 1Vorinostat 1Sunitinib 1Radiosurgery 1Particle Accelerators 1Paclitaxel 1Lidocaine 1Ketamine 1Iohexol 1Immunotherapy, Adoptive 1FS 069 1Embolization, Therapeutic 1Drug Therapy 1Carboplatin 1Blood Coagulation Tests 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Pelvic Neoplasms × FS 069 × Clear all
NCT00186953 2011-09-20

Determination of a Safe Dose of Optison in Pediatric Patients With Solid Tumors

St. Jude Children's Research Hospital

Phase 1 Completed
14 enrolled
Gynecologic

Abdominal Neoplasms, Pelvic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡